Collplant to present at the h.c. wainwright annual growth conference

Rehovot, israel , sept. 5, 2023 /prnewswire/ -- collplant biotechnologies (nasdaq: clgn), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and organ manufacturing, today announced that it will participate at the h.c wainwright annual growth conference, to be held from september 11-13, 2023 in new york, ny.
CLGN Ratings Summary
CLGN Quant Ranking